Frontiers in Medicine (May 2022)

Myxoinflammatory Fibroblastic Sarcoma of the Parotid Gland: First Case Report and Literature Review

  • Changhong Wei,
  • Changhong Wei,
  • Xuejia Yang,
  • Pingping Guo,
  • Xiaoyu Chen,
  • Chunjun Li,
  • Jun Chen,
  • Sufang Zhou,
  • Sufang Zhou

DOI
https://doi.org/10.3389/fmed.2022.833822
Journal volume & issue
Vol. 9

Abstract

Read online

Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare, low-grade malignant soft tissue tumor. Most of the previously reported cases about this tumor were diagnosed within the soft tissues. Here, we report a unique case of MIFS of the right parotid gland in a 39-year-old Chinese male. The tumor primarily consisted of an inflammatory area and a mucus-like area in a migratory distribution. A number of lymphocytes, neutrophils, viral-like cells with large nucleoli, and eosinophilic cytoplasm or Reed-Sternberg-like cells, as well as spindle cells and epithelial-like aberrant cells, were observed within the tumor. They were found to express Vimentin and CD10 protein and no other specific immunohistochemical markers. The various cytomorphology and immunohistochemical features of this tumor were highly consistent with MIFS found in other sites. Therefore, several leading pathologists ultimately confirmed the final diagnosis of MIFS in the right parotid gland after repeated deliberation. To our knowledge, this is the first case of MIFS occurring in the parotid gland. Thus, our study provides a novel basis for identifying the biological behavior of the tumor in MIFS and also allows us to better understand the pathology of this rare tumor.

Keywords